paroxysmal nocturnal hemoglobinuria (PNH) | Page 31 | Aplastic Anemia & MDS International Foundation

paroxysmal nocturnal hemoglobinuria (PNH)

Long-term outcome of fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria

Author(s): 
Pantin J, Tian X, Geller N, Ramos C, Cook L, Cho E, Scheinberg P, Vasu S, Khuu H, Stroncek D, Barrett J, Young NS, Donohue T, Childs RW
Primary Author: 
Pantin J
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
May 2014

Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by intravascular hemolysis,

Bone Marrow Diseases: 

Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria

Author(s): 
Araten DJ, Iori AP, Brown K, Torelli GF, Barberi W, Natalino F, De Propris MS, Girmenia C, Salvatori FM, Zelig O, Foà R, Luzzatto L
Primary Author: 
Araten DJ
Journal Title: 
J Hematol Oncol
Original Publication Date: 
Mar 2014

BACKGROUND:

PNH is associated with abdominal vein thrombosis, which can cause splenomegaly and hypersplenism. The

Bone Marrow Diseases: 

Baseline characteristics and disease burden in patients in the international paroxysmal nocturnal hemoglobinuria registry

Author(s): 
Schrezenmeier H, Muus P, Socié G, Szer J, Urbano-Ispizua A, Maciejewski JP, Brodsky RA, Bessler M, Kanakura Y, Rosse W, Khursigara G, Bedrosian C, Hillmen P
Primary Author: 
Schrezenmeier H
Journal Title: 
Haematologica
Original Publication Date: 
Jan 2014

Bone Marrow Diseases: 

Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria

Author(s): 
Risitano AM, Ricklin D, Huang Y, Reis ES, Chen H, Ricci P, Lin Z, Pascariello C, Raia M, Sica M, Del Vecchio L, Pane F, Lupu F, Notaro R, Resuello RR, Deangelis RA, Lambris JD
Primary Author: 
Risitano AM
Journal Title: 
Blood
Original Publication Date: 
Feb 2014

Bone Marrow Diseases: